1401907-80-9

Upstream product

• 67853-03-6 methyl 3-(hydroxymethyl)benzoate 
• 117924-33-1 di-tert-butyl N,N-diethylphosphoramidite 
• 68695-48-7 di-tert-butyl phosphoric acid tetra-n-butylammonium salt 
• 1129-28-8 3-methoxycarbonylbenzyl bromide 
• 33494-80-3 potassium di-tert-butylphosphate 

Downstream Products

• 1401907-65-0 (4'-(2-(2-(2,6-dichlorophenyl)propan-2-yl)-4-(2-hydroxypropan-2-yl)-1H-imidazol-1-yl)-3,3'-difluoro-5-(methylsulfonyl)biphenyl-4-yl)methyl 3-(phosphonooxymethyl)benzoate 
• 1198393-89-3 3-(((di-tert-butoxyphosphoryl)oxy)methyl)benzoic acid 
• 1401907-84-3 C₄₅H₅₁Cl₂F₂N₂O₉PS 

Relevant academic research and scientific papers

NOVEL PYRROLE DERIVATIVES

There are provided inter alia novel N-phenyl substituted pyrrole derivativesand theiruse in therapy, especially in the treatment of bacterial (e.g. pneumococcal) infections.

ALKYL, FLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS

Disclosed are compounds of Formula (I) and/or salts thereof: (I) wherein: R1 is CH2CH2CF3; R2 is CH2(cyclopropyl), CH(CH3)(cyclopropyl), or CH2CH2CH3/

PRODRUGS OF LXR MODULATING IMIDAZOLE DERIVATIVES

Imidazole prodrugs, pharmaceutically acceptable salts, or isomers thereof, of the invention are disclosed, which are useful as modulators of the activity of liver X receptors (LXR). Pharmaceutical compositions containing the compounds and methods of using